This map shows the geographic impact of G A Omura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G A Omura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G A Omura more than expected).
This network shows the impact of papers produced by G A Omura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G A Omura. The network helps show where G A Omura may publish in the future.
Co-authorship network of co-authors of G A Omura
This figure shows the co-authorship network connecting the top 25 collaborators of G A Omura.
A scholar is included among the top collaborators of G A Omura based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with G A Omura. G A Omura is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
18 of 18 papers shown
1.
Omura, G A. (1996). Chemotherapy for stage IVB or recurrent cancer of the uterine cervix.. PubMed. 123–6.28 indexed citations
2.
Vogler, William R., M. Patrick Stagg, A. A. Bartolucci, et al.. (1994). A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.. PubMed. 8(11). 1847–53.54 indexed citations
Omura, G A, et al.. (1986). Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.. PubMed. 70(4). 533–4.7 indexed citations
7.
Omura, G A, et al.. (1986). Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial.. PubMed. 70(2). 311–2.21 indexed citations
8.
Moore, M. R., et al.. (1985). Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.. PubMed. 69(12). 1457–8.10 indexed citations
Winton, E., et al.. (1985). Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.. PubMed. 69(7-8). 807–11.9 indexed citations
Omura, G A, et al.. (1984). Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: a Southeastern Cancer Study Group trial.. PubMed. 68(12). 1517–8.12 indexed citations
Omura, G A, et al.. (1977). Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.. PubMed. 61(8). 1533–5.7 indexed citations
18.
Omura, G A, R V Smalley, Norman Maldonado, et al.. (1977). Phase II Study of beta-2'-deoxythioguanosine in adult acute leukemia.. PubMed. 61(7). 1379–81.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.